LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Rhea-AI Summary

LifeMD (Nasdaq: LFMD) declared a cash dividend on its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) of $0.5546875 per share.

The dividend is payable April 15, 2026, to holders of record at the close of business on April 3, 2026.

Positive

• Declared cash dividend of $0.5546875 per preferred share
• Clear payment schedule with payment date April 15, 2026 and record date April 3, 2026

Negative

• Payment limited to Series A preferred; common shareholders receive no dividend from this action

News Market Reaction – LFMDP

+0.91%

1 alert

+0.91% News Effect

On the day this news was published, LFMDP gained 0.91%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.

The preferred dividend will be paid on April 15, 2026, to holders of record at the close of business on April 3, 2026.

About LifeMD, Inc.

LifeMD^® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Cautionary Note Regarding Forward Looking Statements

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

Investor Contact
Atul Kavthekar, Chief Financial Officer
investors@lifemd.com

Media Contact
Jessica Friedeman, Chief Business Officer
press@lifemd.com

FAQ

What dividend did LifeMD (LFMD) declare for its Series A preferred stock on March 24, 2026?

LifeMD declared a cash dividend of $0.5546875 per share on the 8.875% Series A preferred stock. According to LifeMD, the dividend applies to Series A cumulative perpetual preferred shares and specifies amount and payment timing.

When will LifeMD (LFMD) pay the Series A preferred dividend and who is eligible?

The dividend will be paid on April 15, 2026 to holders of record as of April 3, 2026. According to LifeMD, only holders of the 8.875% Series A cumulative perpetual preferred stock are eligible.

What is the record date for the LifeMD (LFMD) Series A preferred dividend declared March 24, 2026?

The record date is the close of business on April 3, 2026, determining eligible holders for payment. According to LifeMD, shareholders on that date will receive the April 15, 2026 dividend payment.

How does the declared Series A dividend affect common LifeMD (LFMD) shareholders?

The declared dividend applies solely to Series A preferred stock and does not provide a payment to common shareholders. According to LifeMD, this action only affects holders of the 8.875% preferred shares.

What is the dividend rate associated with LifeMD's (LFMD) Series A preferred announced March 24, 2026?

The Series A preferred carries an 8.875% rate corresponding to the declared cash dividend of $0.5546875 per share. According to LifeMD, the stated rate underlies the specified per-share dividend amount.